Health Equity in Clinical Trials
Dr. Janet Englund, Professor of Pediatrics at the University of Washington Medical School and Director of the Pediatric Infectious Disease Research Group at Seattle Children’s Hospital Center for Clinical and Translational Research joined us for a conversation about vaccine research and clinical trials. We discussed the role her team of researchers and clinicians have played in the Covid19 vaccine clinical trials for children as well as the research on vaccines for Respiratory Syncytial Virus or RSV. Dr. Englund explains the many steps taken in establishing clinical trials and ensuring their safety and the ways which clinical trials can be designed to include more diverse participants.
Listen Now
About Our Guest
Janet A. Englund, MD
Dr. Janet Englund is a professor of infectious diseases in the Department of Pediatrics at the University of Washington School of Medicine and a principal investigator at the Center for Clinical and Translational Research at Seattle Children’s. Her research interests include the study of vaccine-preventable diseases and viral respiratory diseases in young children and immunocompromised hosts, including transplant recipients. She studies new viral vaccines and novel methods of antiviral therapy for respiratory viruses including influenza, adenovirus, parainfluenza viruses, respiratory syncytial virus (RSV) and SARS-CoV-2, the virus that causes COVID-19.
More About Dr. Englund
